Galectin-9: An anticancer molecule for gallbladder carcinoma.

@article{Tadokoro2016Galectin9AA,
  title={Galectin-9: An anticancer molecule for gallbladder carcinoma.},
  author={Tomoko Tadokoro and Asahiro Morishita and Shintarou Fujihara and Hisakazu Iwama and T. Niki and Koji Fujita and Emiko Akashi and Shima Mimura and Kyoko Oura and Teppei Sakamoto and Takako Nomura and Joji Tani and Hisaaki Miyoshi and Hirohito Yoneyama and Takashi Himoto and Mitsuomi Hirashima and Tsutomu Masaki},
  journal={International journal of oncology},
  year={2016},
  volume={48 3},
  pages={1165-74}
}
Gallbladder cancer (GBC) is the most common and aggressive type of biliary tract cancer. There are various histological types of GBC, and the vast majority of GBC cases are adenocarcinomas. Squamous and adenosquamous carcinomas are rare GBC subtypes that are traditionally considered to be more aggressive and to be associated with a poorer prognosis than adenocarcinoma. Galectin-9 (Gal-9), a tandem-repeat-type galectin, has been reported to induce apoptosis-mediated elimination of various… CONTINUE READING
10 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 10 extracted citations

Similar Papers

Loading similar papers…